Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group
In the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Sp...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/1/138 |
_version_ | 1797446877542612992 |
---|---|
author | Esther Redondo Irene Rivero-Calle Enrique Mascarós Daniel Ocaña Isabel Jimeno Ángel Gil José Luis Díaz-Maroto Manuel Linares María Ángeles Onieva-García Fernando González-Romo José Yuste Federico Martinón-Torres |
author_facet | Esther Redondo Irene Rivero-Calle Enrique Mascarós Daniel Ocaña Isabel Jimeno Ángel Gil José Luis Díaz-Maroto Manuel Linares María Ángeles Onieva-García Fernando González-Romo José Yuste Federico Martinón-Torres |
author_sort | Esther Redondo |
collection | DOAJ |
description | In the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Spain caused by prevalent respiratory pathogens, based on the available scientific evidence through extensive bibliographic review and expert opinion. The emergence of COVID-19 as an additional etiological cause of CAP, together with the rapid changes in the availability of vaccines and recommendations against SARS-CoV-2, justifies the need for an update. In addition, new conjugate vaccines of broader spectrum against pneumococcus, existing vaccines targeting influenza and pertussis or upcoming vaccines against respiratory syncytial virus (RSV) will be very useful prophylactic tools to diminish the burden of CAP and all of its derived complications. In this manuscript, we provide practical recommendations for adult vaccination against the pathogens mentioned above, including their contribution against antibiotic resistance. This guide is intended for the individual perspective of protection and not for vaccination policies, as we do not pretend to interfere with the official recommendations of any country. The use of vaccines is a realistic approach to fight these infections and ameliorate the impact of antimicrobial resistance. All of the recently available scientific evidence included in this review gives support to the indications established in this practical guide to reinforce the dissemination and implementation of these recommendations in routine clinical practice. |
first_indexed | 2024-03-09T13:47:54Z |
format | Article |
id | doaj.art-28820a54c3d245239c5ba8945a378105 |
institution | Directory Open Access Journal |
issn | 2079-6382 |
language | English |
last_indexed | 2024-03-09T13:47:54Z |
publishDate | 2023-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Antibiotics |
spelling | doaj.art-28820a54c3d245239c5ba8945a3781052023-11-30T20:56:17ZengMDPI AGAntibiotics2079-63822023-01-0112113810.3390/antibiotics12010138Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention GroupEsther Redondo0Irene Rivero-Calle1Enrique Mascarós2Daniel Ocaña3Isabel Jimeno4Ángel Gil5José Luis Díaz-Maroto6Manuel Linares7María Ángeles Onieva-García8Fernando González-Romo9José Yuste10Federico Martinón-Torres11Infectious, Migrant, Vaccines and Preventive Activities Group of SEMERGEN, International Healthcare Center of Ayuntamiento de Madrid, 28006 Madrid, SpainTranslational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, SpainHealth Department, Hospital la Fe, Primary Care Center Arquitecto Tolsá, 46019 Valencia, SpainPrimary Care Health Care Center Algeciras, 11204 Algeciras, SpainPrimary Care Health Center Isla de Oza, Vaccine Responsible of SEMG, 28034 Madrid, SpainCIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, SpainPrimary Care Health Center Guadalajara, Infectious Diseases Group SEMERGEN, 19161 Guadalajara, SpainInfectious Diseases Group SEMERGEN, Fundación iO, 28006 Madrid, SpainPreventive Medicine Department, Hospital Costa del Sol, 29603 Marbella, SpainClinical Microbiology Department, Health Research Institute (IdISSC), Hospital Clínico San Carlos, School of Medicine, Complutense University of Madrid (UCM), 28040 Madrid, SpainCIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, SpainTranslational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, SpainIn the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Spain caused by prevalent respiratory pathogens, based on the available scientific evidence through extensive bibliographic review and expert opinion. The emergence of COVID-19 as an additional etiological cause of CAP, together with the rapid changes in the availability of vaccines and recommendations against SARS-CoV-2, justifies the need for an update. In addition, new conjugate vaccines of broader spectrum against pneumococcus, existing vaccines targeting influenza and pertussis or upcoming vaccines against respiratory syncytial virus (RSV) will be very useful prophylactic tools to diminish the burden of CAP and all of its derived complications. In this manuscript, we provide practical recommendations for adult vaccination against the pathogens mentioned above, including their contribution against antibiotic resistance. This guide is intended for the individual perspective of protection and not for vaccination policies, as we do not pretend to interfere with the official recommendations of any country. The use of vaccines is a realistic approach to fight these infections and ameliorate the impact of antimicrobial resistance. All of the recently available scientific evidence included in this review gives support to the indications established in this practical guide to reinforce the dissemination and implementation of these recommendations in routine clinical practice.https://www.mdpi.com/2079-6382/12/1/138community-acquired pneumoniainfluenza vaccinationpneumococcal conjugate vaccinespneumococcal polysaccharide vaccineSARS-CoV-2 vaccinesCOVID-19 |
spellingShingle | Esther Redondo Irene Rivero-Calle Enrique Mascarós Daniel Ocaña Isabel Jimeno Ángel Gil José Luis Díaz-Maroto Manuel Linares María Ángeles Onieva-García Fernando González-Romo José Yuste Federico Martinón-Torres Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group Antibiotics community-acquired pneumonia influenza vaccination pneumococcal conjugate vaccines pneumococcal polysaccharide vaccine SARS-CoV-2 vaccines COVID-19 |
title | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group |
title_full | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group |
title_fullStr | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group |
title_full_unstemmed | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group |
title_short | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group |
title_sort | vaccination against community acquired pneumonia in spanish adults practical recommendations by the neumoexperts prevention group |
topic | community-acquired pneumonia influenza vaccination pneumococcal conjugate vaccines pneumococcal polysaccharide vaccine SARS-CoV-2 vaccines COVID-19 |
url | https://www.mdpi.com/2079-6382/12/1/138 |
work_keys_str_mv | AT estherredondo vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT ireneriverocalle vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT enriquemascaros vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT danielocana vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT isabeljimeno vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT angelgil vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT joseluisdiazmaroto vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT manuellinares vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT mariaangelesonievagarcia vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT fernandogonzalezromo vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT joseyuste vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup AT federicomartinontorres vaccinationagainstcommunityacquiredpneumoniainspanishadultspracticalrecommendationsbytheneumoexpertspreventiongroup |